Somatostatin receptor agonist formulations
AssigneeCamurus AB
InventorsCatalin Nistor, Markus Johnsson, Fredrik Tiberg
Life of this patent
Estimating the term…
Loading patent…
AssigneeCamurus AB
InventorsCatalin Nistor, Markus Johnsson, Fredrik Tiberg
Estimating the term…
The present invention relates to compositions forming a low viscosity mixture of: a) 20-50 wt. % of at least one diacyl glycerol; b) 20-54 wt. % of at least one phosphatidyl choline (PC); c) 5-15 wt. % of at least one biocompatible, organic mono-alcoholic solvent; d) 1 to 20 wt. % polar solvent e) 5 to 150 mg/ml of at least one peptide somatostatin receptor agonist comprising pasireotide; f) optionally at least one antioxidant; wherein the ratio of components a:b is in the range 40:60 to 54:46; wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with excess aqueous fluid. The invention further relates to methods of treatment comprising administration of such compositions, and to pre-filled administration devices and kits containing the formulations.
A pre-formulation comprising a low viscosity mixture of:
A process for the formation of a pre-formulation suitable for the administration of a peptide somatostatin receptor agonist to a subject, said process comprising forming a low viscosity mixture of:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.